KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $450.07.

  • Novartis Ag's EPS (Weighted Average and Diluted) fell 1957.65% to $450.07 in Q4 2025 from the same period last year, while for Dec 2025 it was $450.07, marking a year-over-year decrease of 1957.65%. This contributed to the annual value of $1955.8 for FY2025, which is 385.59% down from last year.
  • Latest data reveals that Novartis Ag reported EPS (Weighted Average and Diluted) of $450.07 as of Q4 2025, which was down 1957.65% from $711.19 recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's EPS (Weighted Average and Diluted) ranged from a high of $2696.0 in Q1 2022 and a low of $42.2 during Q2 2023
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $1053.7 (2021), whereas its average is $1117.3.
  • In the last 5 years, Novartis Ag's EPS (Weighted Average and Diluted) plummeted by 9655.66% in 2022 and then skyrocketed by 304930.8% in 2024.
  • Quarter analysis of 5 years shows Novartis Ag's EPS (Weighted Average and Diluted) stood at $1594.6 in 2021, then tumbled by 96.56% to $54.91 in 2022, then surged by 2494.98% to $1424.9 in 2023, then plummeted by 60.72% to $559.63 in 2024, then decreased by 19.58% to $450.07 in 2025.
  • Its last three reported values are $450.07 in Q4 2025, $711.19 for Q3 2025, and $1167.8 during Q2 2025.